Clinical Trial

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

Name: Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer — clinical trial record (NCT06984250)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HFCBB

Recruiting

View on ClinicalTrials.gov →

Summary

Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy

Trial Details

NCT Number	NCT06984250
Lead Sponsor	National Taiwan University Hospital
Conditions	Early Breast Cancer, Ductal Breast Carcinoma In Situ
Enrollment	315 participants
Start Date	2025-02-06
Primary Completion	2027-02-28 (estimated)
Study Completion	2030-02-28 (estimated)
Updated on ClinicalTrials.gov	2025-05-22